DFine, Inc. has announced that it has entered into a distribution agreement with its subsidiary, DFine GmbH for distribution in the Netherlands and Saudi Arabia. The agreement now enables DFine to distribute to seven countries in Europe and the Middle East. The company’s distribution agreements in 2009 expanded its distribution to Austria, the United Kingdom, Greece and Turkey. DFine is currently waiting for regulatory approval for distribution throughout Latin America. Distribution through Latin America will provide the company with more market expansion opportunities, allowing patients suffering from vertebral compression fractures to access advanced medical treatment.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
DFine, Inc., a privately held medical device company based in San Jose, Calif., is dedicated to advancing minimally invasive solutions for treating vertebral compression fractures and other spinal disorders to improve patient quality of life. DFine’s RF Kyphoplasty procedure with the StabiliT® Vertebral Augmentation System provides physicians greater control in the treatment of vertebral compression fractures through site and size specific cavity creation and an ultra high viscosity bone cement over an extended working time using a remote controlled delivery system to stabilize the fracture, relieve pain and improve patient quality of life.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.